Navigation Links
Public Citizen Petitions FDA to Ban Diabetes Drug Avandia, According to Avandia Plaintiffs Attorney Group
Date:11/6/2008

National non-profit organization documents upsurge in negative clinical data associated with use of Avandia, urges FDA commissioner to remove drug from U.S. market immediately

Mineola, N.Y. (Lexis Nexis) November 6, 2008 -- Public Citizen, a non-profit organization representing more than 80,000 consumers nationwide, has petitioned the Commissioner of the U.S. Food and Drug Administration to immediately ban the diabetes drug Avandia, according to Marc Grossman, a member of the Avandia Plaintiffs Steering Committee.

According to the petition, recent clinical studies documented that Avandia has caused an increased risk of heart attacks, heart failure, bone fractures, anemia and retinal edema with vision loss. Perhaps most seriously, the group analyzed 14 cases of liver failure in patients who were taking Avandia, 12 of which resulted in death.

"In the past year, there were 4.6 million (Avandia) prescriptions filled, thus exposing hundreds of thousands of people with diabetes to a drug that is clearly doing more harm than good," according to the Public Citizen petition. "Thus, it is urgent for the FDA to immediately ban rosiglitazone (Avandia)."

The Avandia Plaintiffs Steering Committee has been tracking the reports of multiple serious side effects from Avandia for the past year and represents a number of plaintiffs in litigation against the manufacturer of the drug, GlaxoSmithKline. Many nationwide lawsuits have been centralized in Federal court in the Eastern District of Pennsylvania in front of Hon. Cynthia Rufe, (In Re: Avandia Marketing, Sales Practices and Products Liability Litigation, 2:07-md-01871-CMR). This litigation involves thousands of claims for injuries ranging from death and heart attack to vision loss and bone fractures.

"The Public Citizen petition, along with prior recommendations against the use of Avandia from both the American Diabetes Association and the European Association for the Study of Diabetes, is certainly a step in the right direction," said Vance Andrus, lead counsel for the Avandia Plaintiffs Steering Committee. "Many doctors and patients were led to believe that this was a safe and effective drug and, as a result, their lives were put in danger."

Any adverse reactions experienced with the use of Avandia should be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1572304.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. International Medical Corps Continues Delivering Emergency Relief in Democratic Republic of Congo as Potential for Renewed Fighting Threatens to Deepen Crisis
2. Media Affects Public Perception of Infectious Diseases
3. International Medical Corps Continues Delivering Emergency Relief Amid Violence in Democratic Republic of Congo
4. Evolution Physical Therapy First Clinic in Southern California to Introduce NASA-Designed Anti-Gravity Treadmill for Public Use
5. NQF Endorses Guidelines for Consumer-Focused Public Reporting
6. Teach For America and Lilly Launch Program to Match Lilly Employees with Teachers in Underserved Public Schools
7. ASPH and APHA Collaborate to Shore up the Public Health Workforce Pipeline:
8. Home Health Leaders Launch Alliance to Sponsor Research and to Educate Public and Policymakers on Sectors Contributions to National Health Reform
9. Gather and Harvard Health Publications Launch New Programs to Bring Harvard Medical School Doctors Expertise Online
10. Bloomberg School of Public Health to lead nationwide aging study
11. New State Public Health Department Survey Results Highlight Available Resources for Men and Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will ... the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey ... Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, ... In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the ... have extremely low property-tax rates, which contributes to the relatively lower cost of ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
Breaking Medicine Technology: